11-93795026-G-C

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_004268.5(MED17):ā€‹c.978G>Cā€‹(p.Val326=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00248 in 1,614,080 control chromosomes in the GnomAD database, including 123 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…). Synonymous variant affecting the same amino acid position (i.e. V326V) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.0035 ( 13 hom., cov: 32)
Exomes š‘“: 0.0024 ( 110 hom. )

Consequence

MED17
NM_004268.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.309
Variant links:
Genes affected
MED17 (HGNC:2375): (mediator complex subunit 17) The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 11-93795026-G-C is Benign according to our data. Variant chr11-93795026-G-C is described in ClinVar as [Benign]. Clinvar id is 129606.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-93795026-G-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.309 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0518 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MED17NM_004268.5 linkuse as main transcriptc.978G>C p.Val326= synonymous_variant 6/12 ENST00000251871.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MED17ENST00000251871.9 linkuse as main transcriptc.978G>C p.Val326= synonymous_variant 6/121 NM_004268.5 P1Q9NVC6-1

Frequencies

GnomAD3 genomes
AF:
0.00354
AC:
538
AN:
152102
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00509
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0571
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00555
AC:
1395
AN:
251404
Hom.:
52
AF XY:
0.00509
AC XY:
691
AN XY:
135886
show subpopulations
Gnomad AFR exome
AF:
0.00474
Gnomad AMR exome
AF:
0.000347
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0678
Gnomad SAS exome
AF:
0.000915
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.00277
GnomAD4 exome
AF:
0.00237
AC:
3458
AN:
1461860
Hom.:
110
Cov.:
31
AF XY:
0.00225
AC XY:
1635
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.00594
Gnomad4 AMR exome
AF:
0.000268
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0744
Gnomad4 SAS exome
AF:
0.000846
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000324
Gnomad4 OTH exome
AF:
0.00295
GnomAD4 genome
AF:
0.00354
AC:
539
AN:
152220
Hom.:
13
Cov.:
32
AF XY:
0.00370
AC XY:
275
AN XY:
74406
show subpopulations
Gnomad4 AFR
AF:
0.00510
Gnomad4 AMR
AF:
0.00105
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0572
Gnomad4 SAS
AF:
0.00145
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.000380
Hom.:
1
Bravo
AF:
0.00432
Asia WGS
AF:
0.0180
AC:
64
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 21, 2019- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMay 24, 2013- -
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
6.1
DANN
Benign
0.73
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2276311; hg19: chr11-93528192; API